nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS2—Triamcinolone—multiple sclerosis	0.252	0.339	CbGbCtD
Tenoxicam—PTGS2—Betamethasone—multiple sclerosis	0.216	0.291	CbGbCtD
Tenoxicam—PTGS2—Dexamethasone—multiple sclerosis	0.126	0.169	CbGbCtD
Tenoxicam—SLC22A8—Methotrexate—multiple sclerosis	0.107	0.144	CbGbCtD
Tenoxicam—CYP2C9—Dexamethasone—multiple sclerosis	0.0428	0.0575	CbGbCtD
Tenoxicam—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00168	0.159	CbGdCrCtD
Tenoxicam—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.00165	0.156	CbGdCrCtD
Tenoxicam—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.00165	0.156	CbGdCrCtD
Tenoxicam—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.00162	0.153	CbGdCrCtD
Tenoxicam—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00101	0.0958	CbGdCrCtD
Tenoxicam—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000998	0.0942	CbGdCrCtD
Tenoxicam—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000998	0.0942	CbGdCrCtD
Tenoxicam—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000976	0.0921	CbGdCrCtD
Tenoxicam—Asthma—Triamcinolone—multiple sclerosis	0.000956	0.00392	CcSEcCtD
Tenoxicam—Decreased appetite—Cladribine—multiple sclerosis	0.000953	0.00391	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000946	0.00388	CcSEcCtD
Tenoxicam—Fatigue—Cladribine—multiple sclerosis	0.000945	0.00387	CcSEcCtD
Tenoxicam—Constipation—Cladribine—multiple sclerosis	0.000937	0.00384	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000923	0.00379	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000913	0.00375	CcSEcCtD
Tenoxicam—Myocardial infarction—Prednisolone—multiple sclerosis	0.000908	0.00372	CcSEcCtD
Tenoxicam—Cardiac failure—Prednisone—multiple sclerosis	0.000895	0.00367	CcSEcCtD
Tenoxicam—Erythema—Mitoxantrone—multiple sclerosis	0.000882	0.00362	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000874	0.00358	CcSEcCtD
Tenoxicam—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000872	0.00358	CcSEcCtD
Tenoxicam—Urticaria—Cladribine—multiple sclerosis	0.00087	0.00357	CcSEcCtD
Tenoxicam—Skin disorder—Azathioprine—multiple sclerosis	0.000865	0.00355	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00084	0.00344	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000838	0.00344	CcSEcCtD
Tenoxicam—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000835	0.00343	CcSEcCtD
Tenoxicam—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000833	0.00342	CcSEcCtD
Tenoxicam—Anaemia—Mitoxantrone—multiple sclerosis	0.000816	0.00335	CcSEcCtD
Tenoxicam—Hypersensitivity—Cladribine—multiple sclerosis	0.000807	0.00331	CcSEcCtD
Tenoxicam—Visual impairment—Prednisolone—multiple sclerosis	0.000801	0.00329	CcSEcCtD
Tenoxicam—Leukopenia—Mitoxantrone—multiple sclerosis	0.00079	0.00324	CcSEcCtD
Tenoxicam—Asthenia—Cladribine—multiple sclerosis	0.000786	0.00322	CcSEcCtD
Tenoxicam—Pruritus—Cladribine—multiple sclerosis	0.000775	0.00318	CcSEcCtD
Tenoxicam—Visual disturbance—Methotrexate—multiple sclerosis	0.00077	0.00316	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000769	0.00315	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000762	0.00313	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000762	0.00313	CcSEcCtD
Tenoxicam—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000758	0.00311	CcSEcCtD
Tenoxicam—Myocardial infarction—Betamethasone—multiple sclerosis	0.000758	0.00311	CcSEcCtD
Tenoxicam—Diarrhoea—Cladribine—multiple sclerosis	0.00075	0.00307	CcSEcCtD
Tenoxicam—Visual impairment—Methylprednisolone—multiple sclerosis	0.000735	0.00302	CcSEcCtD
Tenoxicam—Dizziness—Cladribine—multiple sclerosis	0.000725	0.00297	CcSEcCtD
Tenoxicam—Erythema—Prednisolone—multiple sclerosis	0.000724	0.00297	CcSEcCtD
Tenoxicam—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00072	0.00295	CcSEcCtD
Tenoxicam—Oedema—Mitoxantrone—multiple sclerosis	0.00072	0.00295	CcSEcCtD
Tenoxicam—Eye disorder—Methylprednisolone—multiple sclerosis	0.000713	0.00293	CcSEcCtD
Tenoxicam—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000708	0.0029	CcSEcCtD
Tenoxicam—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000705	0.00289	CcSEcCtD
Tenoxicam—Skin disorder—Mitoxantrone—multiple sclerosis	0.0007	0.00287	CcSEcCtD
Tenoxicam—Vomiting—Cladribine—multiple sclerosis	0.000697	0.00286	CcSEcCtD
Tenoxicam—Angiopathy—Methylprednisolone—multiple sclerosis	0.000692	0.00284	CcSEcCtD
Tenoxicam—Rash—Cladribine—multiple sclerosis	0.000691	0.00283	CcSEcCtD
Tenoxicam—Dermatitis—Cladribine—multiple sclerosis	0.00069	0.00283	CcSEcCtD
Tenoxicam—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000689	0.00283	CcSEcCtD
Tenoxicam—Anorexia—Mitoxantrone—multiple sclerosis	0.000687	0.00282	CcSEcCtD
Tenoxicam—Headache—Cladribine—multiple sclerosis	0.000686	0.00282	CcSEcCtD
Tenoxicam—Visual impairment—Dexamethasone—multiple sclerosis	0.000669	0.00274	CcSEcCtD
Tenoxicam—Visual impairment—Betamethasone—multiple sclerosis	0.000669	0.00274	CcSEcCtD
Tenoxicam—Mental disorder—Methylprednisolone—multiple sclerosis	0.000669	0.00274	CcSEcCtD
Tenoxicam—Erythema—Triamcinolone—multiple sclerosis	0.000666	0.00273	CcSEcCtD
Tenoxicam—Erythema—Methylprednisolone—multiple sclerosis	0.000664	0.00272	CcSEcCtD
Tenoxicam—Malnutrition—Methylprednisolone—multiple sclerosis	0.000664	0.00272	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000664	0.00272	CcSEcCtD
Tenoxicam—Angioedema—Prednisolone—multiple sclerosis	0.000662	0.00271	CcSEcCtD
Tenoxicam—Myocardial infarction—Prednisone—multiple sclerosis	0.00066	0.00271	CcSEcCtD
Tenoxicam—Breast disorder—Methotrexate—multiple sclerosis	0.00066	0.00271	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000657	0.0027	CcSEcCtD
Tenoxicam—Hypersensitivity—Azathioprine—multiple sclerosis	0.000656	0.00269	CcSEcCtD
Tenoxicam—Nausea—Cladribine—multiple sclerosis	0.000651	0.00267	CcSEcCtD
Tenoxicam—Vertigo—Prednisolone—multiple sclerosis	0.00065	0.00267	CcSEcCtD
Tenoxicam—Eye disorder—Dexamethasone—multiple sclerosis	0.000649	0.00266	CcSEcCtD
Tenoxicam—Eye disorder—Betamethasone—multiple sclerosis	0.000649	0.00266	CcSEcCtD
Tenoxicam—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000642	0.00263	CcSEcCtD
Tenoxicam—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000634	0.0026	CcSEcCtD
Tenoxicam—Asthma—Methotrexate—multiple sclerosis	0.000631	0.00259	CcSEcCtD
Tenoxicam—Angiopathy—Dexamethasone—multiple sclerosis	0.00063	0.00258	CcSEcCtD
Tenoxicam—Angiopathy—Betamethasone—multiple sclerosis	0.00063	0.00258	CcSEcCtD
Tenoxicam—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000626	0.00257	CcSEcCtD
Tenoxicam—Fatigue—Mitoxantrone—multiple sclerosis	0.000621	0.00255	CcSEcCtD
Tenoxicam—Constipation—Mitoxantrone—multiple sclerosis	0.000616	0.00253	CcSEcCtD
Tenoxicam—Diarrhoea—Azathioprine—multiple sclerosis	0.00061	0.0025	CcSEcCtD
Tenoxicam—Angioedema—Triamcinolone—multiple sclerosis	0.000608	0.0025	CcSEcCtD
Tenoxicam—Angioedema—Methylprednisolone—multiple sclerosis	0.000607	0.00249	CcSEcCtD
Tenoxicam—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000605	0.00248	CcSEcCtD
Tenoxicam—Erythema—Dexamethasone—multiple sclerosis	0.000604	0.00248	CcSEcCtD
Tenoxicam—Erythema—Betamethasone—multiple sclerosis	0.000604	0.00248	CcSEcCtD
Tenoxicam—Vertigo—Triamcinolone—multiple sclerosis	0.000598	0.00245	CcSEcCtD
Tenoxicam—Vertigo—Methylprednisolone—multiple sclerosis	0.000597	0.00245	CcSEcCtD
Tenoxicam—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000591	0.00242	CcSEcCtD
Tenoxicam—Oedema—Prednisolone—multiple sclerosis	0.000591	0.00242	CcSEcCtD
Tenoxicam—Dizziness—Azathioprine—multiple sclerosis	0.000589	0.00242	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000576	0.00236	CcSEcCtD
Tenoxicam—Urticaria—Mitoxantrone—multiple sclerosis	0.000572	0.00235	CcSEcCtD
Tenoxicam—Vomiting—Azathioprine—multiple sclerosis	0.000566	0.00232	CcSEcCtD
Tenoxicam—Eye disorder—Prednisone—multiple sclerosis	0.000565	0.00232	CcSEcCtD
Tenoxicam—Rash—Azathioprine—multiple sclerosis	0.000562	0.0023	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000562	0.0023	CcSEcCtD
Tenoxicam—Dermatitis—Azathioprine—multiple sclerosis	0.000561	0.0023	CcSEcCtD
Tenoxicam—Headache—Azathioprine—multiple sclerosis	0.000558	0.00229	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000558	0.00229	CcSEcCtD
Tenoxicam—Dry mouth—Triamcinolone—multiple sclerosis	0.000554	0.00227	CcSEcCtD
Tenoxicam—Angioedema—Betamethasone—multiple sclerosis	0.000552	0.00226	CcSEcCtD
Tenoxicam—Angioedema—Dexamethasone—multiple sclerosis	0.000552	0.00226	CcSEcCtD
Tenoxicam—Stomatitis—Methotrexate—multiple sclerosis	0.000548	0.00225	CcSEcCtD
Tenoxicam—Angiopathy—Prednisone—multiple sclerosis	0.000548	0.00225	CcSEcCtD
Tenoxicam—Immune system disorder—Prednisone—multiple sclerosis	0.000546	0.00224	CcSEcCtD
Tenoxicam—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000543	0.00223	CcSEcCtD
Tenoxicam—Oedema—Triamcinolone—multiple sclerosis	0.000543	0.00223	CcSEcCtD
Tenoxicam—Vertigo—Dexamethasone—multiple sclerosis	0.000543	0.00223	CcSEcCtD
Tenoxicam—Vertigo—Betamethasone—multiple sclerosis	0.000543	0.00223	CcSEcCtD
Tenoxicam—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000542	0.00222	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000532	0.00218	CcSEcCtD
Tenoxicam—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000532	0.00218	CcSEcCtD
Tenoxicam—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000531	0.00218	CcSEcCtD
Tenoxicam—Mental disorder—Prednisone—multiple sclerosis	0.000529	0.00217	CcSEcCtD
Tenoxicam—Nausea—Azathioprine—multiple sclerosis	0.000529	0.00217	CcSEcCtD
Tenoxicam—Skin disorder—Methylprednisolone—multiple sclerosis	0.000527	0.00216	CcSEcCtD
Tenoxicam—Erythema—Prednisone—multiple sclerosis	0.000526	0.00216	CcSEcCtD
Tenoxicam—Malnutrition—Prednisone—multiple sclerosis	0.000526	0.00216	CcSEcCtD
Tenoxicam—Agranulocytosis—Methotrexate—multiple sclerosis	0.000525	0.00215	CcSEcCtD
Tenoxicam—Asthenia—Mitoxantrone—multiple sclerosis	0.000517	0.00212	CcSEcCtD
Tenoxicam—Hepatitis—Methotrexate—multiple sclerosis	0.000505	0.00207	CcSEcCtD
Tenoxicam—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000499	0.00205	CcSEcCtD
Tenoxicam—Urethral disorder—Methotrexate—multiple sclerosis	0.000495	0.00203	CcSEcCtD
Tenoxicam—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000493	0.00202	CcSEcCtD
Tenoxicam—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000493	0.00202	CcSEcCtD
Tenoxicam—Oedema—Betamethasone—multiple sclerosis	0.000493	0.00202	CcSEcCtD
Tenoxicam—Oedema—Dexamethasone—multiple sclerosis	0.000493	0.00202	CcSEcCtD
Tenoxicam—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000493	0.00202	CcSEcCtD
Tenoxicam—Visual impairment—Methotrexate—multiple sclerosis	0.000487	0.002	CcSEcCtD
Tenoxicam—Anaemia—Prednisone—multiple sclerosis	0.000486	0.00199	CcSEcCtD
Tenoxicam—Dyspnoea—Triamcinolone—multiple sclerosis	0.000484	0.00199	CcSEcCtD
Tenoxicam—Nervous system disorder—Betamethasone—multiple sclerosis	0.000484	0.00198	CcSEcCtD
Tenoxicam—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000484	0.00198	CcSEcCtD
Tenoxicam—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000483	0.00198	CcSEcCtD
Tenoxicam—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000483	0.00198	CcSEcCtD
Tenoxicam—Angioedema—Prednisone—multiple sclerosis	0.000481	0.00197	CcSEcCtD
Tenoxicam—Dyspepsia—Triamcinolone—multiple sclerosis	0.000478	0.00196	CcSEcCtD
Tenoxicam—Erythema multiforme—Methotrexate—multiple sclerosis	0.000478	0.00196	CcSEcCtD
Tenoxicam—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000477	0.00196	CcSEcCtD
Tenoxicam—Vertigo—Prednisone—multiple sclerosis	0.000473	0.00194	CcSEcCtD
Tenoxicam—Eye disorder—Methotrexate—multiple sclerosis	0.000472	0.00194	CcSEcCtD
Tenoxicam—Anorexia—Dexamethasone—multiple sclerosis	0.00047	0.00193	CcSEcCtD
Tenoxicam—Anorexia—Betamethasone—multiple sclerosis	0.00047	0.00193	CcSEcCtD
Tenoxicam—Urticaria—Prednisolone—multiple sclerosis	0.000469	0.00193	CcSEcCtD
Tenoxicam—Cardiac disorder—Methotrexate—multiple sclerosis	0.000469	0.00192	CcSEcCtD
Tenoxicam—Fatigue—Triamcinolone—multiple sclerosis	0.000468	0.00192	CcSEcCtD
Tenoxicam—Fatigue—Methylprednisolone—multiple sclerosis	0.000467	0.00192	CcSEcCtD
Tenoxicam—Angiopathy—Methotrexate—multiple sclerosis	0.000458	0.00188	CcSEcCtD
Tenoxicam—Vomiting—Mitoxantrone—multiple sclerosis	0.000458	0.00188	CcSEcCtD
Tenoxicam—Immune system disorder—Methotrexate—multiple sclerosis	0.000456	0.00187	CcSEcCtD
Tenoxicam—Rash—Mitoxantrone—multiple sclerosis	0.000454	0.00186	CcSEcCtD
Tenoxicam—Dermatitis—Mitoxantrone—multiple sclerosis	0.000454	0.00186	CcSEcCtD
Tenoxicam—Headache—Mitoxantrone—multiple sclerosis	0.000451	0.00185	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000445	0.00182	CcSEcCtD
Tenoxicam—Mental disorder—Methotrexate—multiple sclerosis	0.000443	0.00181	CcSEcCtD
Tenoxicam—Erythema—Methotrexate—multiple sclerosis	0.00044	0.0018	CcSEcCtD
Tenoxicam—Malnutrition—Methotrexate—multiple sclerosis	0.00044	0.0018	CcSEcCtD
Tenoxicam—Hypersensitivity—Prednisolone—multiple sclerosis	0.000435	0.00179	CcSEcCtD
Tenoxicam—Dyspepsia—Dexamethasone—multiple sclerosis	0.000434	0.00178	CcSEcCtD
Tenoxicam—Dyspepsia—Betamethasone—multiple sclerosis	0.000434	0.00178	CcSEcCtD
Tenoxicam—Urticaria—Triamcinolone—multiple sclerosis	0.000432	0.00177	CcSEcCtD
Tenoxicam—Urticaria—Methylprednisolone—multiple sclerosis	0.000431	0.00177	CcSEcCtD
Tenoxicam—Oedema—Prednisone—multiple sclerosis	0.000429	0.00176	CcSEcCtD
Tenoxicam—Anaphylactic shock—Prednisone—multiple sclerosis	0.000429	0.00176	CcSEcCtD
Tenoxicam—Decreased appetite—Dexamethasone—multiple sclerosis	0.000429	0.00176	CcSEcCtD
Tenoxicam—Decreased appetite—Betamethasone—multiple sclerosis	0.000429	0.00176	CcSEcCtD
Tenoxicam—Nausea—Mitoxantrone—multiple sclerosis	0.000428	0.00175	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000426	0.00175	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000426	0.00175	CcSEcCtD
Tenoxicam—Fatigue—Dexamethasone—multiple sclerosis	0.000425	0.00174	CcSEcCtD
Tenoxicam—Fatigue—Betamethasone—multiple sclerosis	0.000425	0.00174	CcSEcCtD
Tenoxicam—Nervous system disorder—Prednisone—multiple sclerosis	0.000421	0.00173	CcSEcCtD
Tenoxicam—Skin disorder—Prednisone—multiple sclerosis	0.000417	0.00171	CcSEcCtD
Tenoxicam—Anorexia—Prednisone—multiple sclerosis	0.000409	0.00168	CcSEcCtD
Tenoxicam—Anaemia—Methotrexate—multiple sclerosis	0.000406	0.00167	CcSEcCtD
Tenoxicam—Hypersensitivity—Triamcinolone—multiple sclerosis	0.0004	0.00164	CcSEcCtD
Tenoxicam—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000399	0.00164	CcSEcCtD
Tenoxicam—Vertigo—Methotrexate—multiple sclerosis	0.000395	0.00162	CcSEcCtD
Tenoxicam—Leukopenia—Methotrexate—multiple sclerosis	0.000394	0.00161	CcSEcCtD
Tenoxicam—Urticaria—Dexamethasone—multiple sclerosis	0.000392	0.00161	CcSEcCtD
Tenoxicam—Urticaria—Betamethasone—multiple sclerosis	0.000392	0.00161	CcSEcCtD
Tenoxicam—Dizziness—Prednisolone—multiple sclerosis	0.000391	0.0016	CcSEcCtD
Tenoxicam—Asthenia—Triamcinolone—multiple sclerosis	0.00039	0.0016	CcSEcCtD
Tenoxicam—Asthenia—Methylprednisolone—multiple sclerosis	0.000389	0.0016	CcSEcCtD
Tenoxicam—Pruritus—Triamcinolone—multiple sclerosis	0.000384	0.00158	CcSEcCtD
Tenoxicam—Pruritus—Methylprednisolone—multiple sclerosis	0.000384	0.00157	CcSEcCtD
Tenoxicam—Dyspepsia—Prednisone—multiple sclerosis	0.000378	0.00155	CcSEcCtD
Tenoxicam—Decreased appetite—Prednisone—multiple sclerosis	0.000373	0.00153	CcSEcCtD
Tenoxicam—Rash—Prednisolone—multiple sclerosis	0.000373	0.00153	CcSEcCtD
Tenoxicam—Dermatitis—Prednisolone—multiple sclerosis	0.000372	0.00153	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000372	0.00152	CcSEcCtD
Tenoxicam—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000371	0.00152	CcSEcCtD
Tenoxicam—Fatigue—Prednisone—multiple sclerosis	0.00037	0.00152	CcSEcCtD
Tenoxicam—Headache—Prednisolone—multiple sclerosis	0.00037	0.00152	CcSEcCtD
Tenoxicam—Constipation—Prednisone—multiple sclerosis	0.000367	0.00151	CcSEcCtD
Tenoxicam—Dizziness—Triamcinolone—multiple sclerosis	0.000359	0.00147	CcSEcCtD
Tenoxicam—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000359	0.00147	CcSEcCtD
Tenoxicam—Dizziness—Methylprednisolone—multiple sclerosis	0.000359	0.00147	CcSEcCtD
Tenoxicam—Asthenia—Dexamethasone—multiple sclerosis	0.000354	0.00145	CcSEcCtD
Tenoxicam—Asthenia—Betamethasone—multiple sclerosis	0.000354	0.00145	CcSEcCtD
Tenoxicam—Nervous system disorder—Methotrexate—multiple sclerosis	0.000352	0.00144	CcSEcCtD
Tenoxicam—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000351	0.00144	CcSEcCtD
Tenoxicam—Nausea—Prednisolone—multiple sclerosis	0.000351	0.00144	CcSEcCtD
Tenoxicam—Pruritus—Dexamethasone—multiple sclerosis	0.000349	0.00143	CcSEcCtD
Tenoxicam—Pruritus—Betamethasone—multiple sclerosis	0.000349	0.00143	CcSEcCtD
Tenoxicam—Skin disorder—Methotrexate—multiple sclerosis	0.000349	0.00143	CcSEcCtD
Tenoxicam—Vomiting—Triamcinolone—multiple sclerosis	0.000345	0.00142	CcSEcCtD
Tenoxicam—Vomiting—Methylprednisolone—multiple sclerosis	0.000345	0.00141	CcSEcCtD
Tenoxicam—Rash—Triamcinolone—multiple sclerosis	0.000343	0.00141	CcSEcCtD
Tenoxicam—Dermatitis—Triamcinolone—multiple sclerosis	0.000342	0.0014	CcSEcCtD
Tenoxicam—Anorexia—Methotrexate—multiple sclerosis	0.000342	0.0014	CcSEcCtD
Tenoxicam—Rash—Methylprednisolone—multiple sclerosis	0.000342	0.0014	CcSEcCtD
Tenoxicam—Dermatitis—Methylprednisolone—multiple sclerosis	0.000342	0.0014	CcSEcCtD
Tenoxicam—Urticaria—Prednisone—multiple sclerosis	0.000341	0.0014	CcSEcCtD
Tenoxicam—Headache—Triamcinolone—multiple sclerosis	0.00034	0.0014	CcSEcCtD
Tenoxicam—Headache—Methylprednisolone—multiple sclerosis	0.00034	0.00139	CcSEcCtD
Tenoxicam—Diarrhoea—Dexamethasone—multiple sclerosis	0.000337	0.00138	CcSEcCtD
Tenoxicam—Diarrhoea—Betamethasone—multiple sclerosis	0.000337	0.00138	CcSEcCtD
Tenoxicam—Dizziness—Betamethasone—multiple sclerosis	0.000326	0.00134	CcSEcCtD
Tenoxicam—Dizziness—Dexamethasone—multiple sclerosis	0.000326	0.00134	CcSEcCtD
Tenoxicam—Nausea—Triamcinolone—multiple sclerosis	0.000323	0.00132	CcSEcCtD
Tenoxicam—Nausea—Methylprednisolone—multiple sclerosis	0.000322	0.00132	CcSEcCtD
Tenoxicam—Dyspnoea—Methotrexate—multiple sclerosis	0.00032	0.00131	CcSEcCtD
Tenoxicam—Hypersensitivity—Prednisone—multiple sclerosis	0.000316	0.0013	CcSEcCtD
Tenoxicam—Dyspepsia—Methotrexate—multiple sclerosis	0.000316	0.0013	CcSEcCtD
Tenoxicam—Vomiting—Betamethasone—multiple sclerosis	0.000313	0.00129	CcSEcCtD
Tenoxicam—Vomiting—Dexamethasone—multiple sclerosis	0.000313	0.00129	CcSEcCtD
Tenoxicam—Decreased appetite—Methotrexate—multiple sclerosis	0.000312	0.00128	CcSEcCtD
Tenoxicam—Rash—Dexamethasone—multiple sclerosis	0.000311	0.00128	CcSEcCtD
Tenoxicam—Rash—Betamethasone—multiple sclerosis	0.000311	0.00128	CcSEcCtD
Tenoxicam—Dermatitis—Betamethasone—multiple sclerosis	0.000311	0.00127	CcSEcCtD
Tenoxicam—Dermatitis—Dexamethasone—multiple sclerosis	0.000311	0.00127	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00031	0.00127	CcSEcCtD
Tenoxicam—Fatigue—Methotrexate—multiple sclerosis	0.000309	0.00127	CcSEcCtD
Tenoxicam—Headache—Betamethasone—multiple sclerosis	0.000309	0.00127	CcSEcCtD
Tenoxicam—Headache—Dexamethasone—multiple sclerosis	0.000309	0.00127	CcSEcCtD
Tenoxicam—Asthenia—Prednisone—multiple sclerosis	0.000308	0.00126	CcSEcCtD
Tenoxicam—Pruritus—Prednisone—multiple sclerosis	0.000304	0.00125	CcSEcCtD
Tenoxicam—Diarrhoea—Prednisone—multiple sclerosis	0.000294	0.0012	CcSEcCtD
Tenoxicam—Nausea—Dexamethasone—multiple sclerosis	0.000293	0.0012	CcSEcCtD
Tenoxicam—Nausea—Betamethasone—multiple sclerosis	0.000293	0.0012	CcSEcCtD
Tenoxicam—Urticaria—Methotrexate—multiple sclerosis	0.000285	0.00117	CcSEcCtD
Tenoxicam—Dizziness—Prednisone—multiple sclerosis	0.000284	0.00116	CcSEcCtD
Tenoxicam—Vomiting—Prednisone—multiple sclerosis	0.000273	0.00112	CcSEcCtD
Tenoxicam—Rash—Prednisone—multiple sclerosis	0.000271	0.00111	CcSEcCtD
Tenoxicam—Dermatitis—Prednisone—multiple sclerosis	0.00027	0.00111	CcSEcCtD
Tenoxicam—Headache—Prednisone—multiple sclerosis	0.000269	0.0011	CcSEcCtD
Tenoxicam—Hypersensitivity—Methotrexate—multiple sclerosis	0.000264	0.00108	CcSEcCtD
Tenoxicam—Asthenia—Methotrexate—multiple sclerosis	0.000257	0.00106	CcSEcCtD
Tenoxicam—Nausea—Prednisone—multiple sclerosis	0.000255	0.00105	CcSEcCtD
Tenoxicam—Pruritus—Methotrexate—multiple sclerosis	0.000254	0.00104	CcSEcCtD
Tenoxicam—Diarrhoea—Methotrexate—multiple sclerosis	0.000246	0.00101	CcSEcCtD
Tenoxicam—Dizziness—Methotrexate—multiple sclerosis	0.000237	0.000973	CcSEcCtD
Tenoxicam—Vomiting—Methotrexate—multiple sclerosis	0.000228	0.000936	CcSEcCtD
Tenoxicam—Rash—Methotrexate—multiple sclerosis	0.000226	0.000928	CcSEcCtD
Tenoxicam—Dermatitis—Methotrexate—multiple sclerosis	0.000226	0.000927	CcSEcCtD
Tenoxicam—Headache—Methotrexate—multiple sclerosis	0.000225	0.000922	CcSEcCtD
Tenoxicam—Nausea—Methotrexate—multiple sclerosis	0.000213	0.000874	CcSEcCtD
Tenoxicam—PTGS2—S1P1 pathway—S1PR1—multiple sclerosis	7.04e-05	0.0592	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	5.36e-05	0.0451	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	3.45e-05	0.0291	CbGpPWpGaD
Tenoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	3.11e-05	0.0262	CbGpPWpGaD
Tenoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	3.11e-05	0.0262	CbGpPWpGaD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	3.11e-05	0.0262	CbGpPWpGaD
Tenoxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	3.09e-05	0.026	CbGpPWpGaD
Tenoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	3.05e-05	0.0256	CbGpPWpGaD
Tenoxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	3.05e-05	0.0256	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	2.54e-05	0.0213	CbGpPWpGaD
Tenoxicam—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	2.47e-05	0.0208	CbGpPWpGaD
Tenoxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	2.16e-05	0.0182	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	2.05e-05	0.0173	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	1.98e-05	0.0166	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	1.98e-05	0.0166	CbGpPWpGaD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	1.95e-05	0.0164	CbGpPWpGaD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	1.95e-05	0.0164	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	1.85e-05	0.0156	CbGpPWpGaD
Tenoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	1.7e-05	0.0143	CbGpPWpGaD
Tenoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	1.65e-05	0.0139	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	1.62e-05	0.0136	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	1.62e-05	0.0136	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	1.6e-05	0.0135	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	1.6e-05	0.0135	CbGpPWpGaD
Tenoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	1.51e-05	0.0127	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	1.48e-05	0.0124	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	1.41e-05	0.0119	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	1.4e-05	0.0118	CbGpPWpGaD
Tenoxicam—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	1.14e-05	0.00961	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	1.12e-05	0.00942	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	1.1e-05	0.00925	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	1.07e-05	0.00899	CbGpPWpGaD
Tenoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.02e-05	0.00857	CbGpPWpGaD
Tenoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	9.99e-06	0.00841	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.81e-06	0.00825	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	9.8e-06	0.00824	CbGpPWpGaD
Tenoxicam—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	9.53e-06	0.00801	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.41e-06	0.00792	CbGpPWpGaD
Tenoxicam—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	9.22e-06	0.00776	CbGpPWpGaD
Tenoxicam—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	9.07e-06	0.00763	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	8.96e-06	0.00754	CbGpPWpGaD
Tenoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	8.88e-06	0.00747	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	8.51e-06	0.00716	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	8.51e-06	0.00716	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.4e-06	0.00706	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.4e-06	0.00706	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	7.76e-06	0.00653	CbGpPWpGaD
Tenoxicam—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	7.32e-06	0.00616	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.14e-06	0.006	CbGpPWpGaD
Tenoxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.86e-06	0.00577	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	6.81e-06	0.00573	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	6.46e-06	0.00544	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	6.45e-06	0.00542	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.22e-06	0.00523	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.22e-06	0.00523	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	6.09e-06	0.00512	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	5.79e-06	0.00487	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	5.74e-06	0.00483	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	5.68e-06	0.00477	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.64e-06	0.00474	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	5.4e-06	0.00455	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	5.38e-06	0.00453	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.18e-06	0.00436	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.99e-06	0.00419	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.94e-06	0.00415	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.94e-06	0.00415	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.91e-06	0.00413	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.84e-06	0.00407	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.8e-06	0.00404	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.7e-06	0.00395	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.62e-06	0.00389	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	4.51e-06	0.00379	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.47e-06	0.00376	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	4.46e-06	0.00375	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.45e-06	0.00374	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	4.27e-06	0.00359	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	4.18e-06	0.00352	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	4.12e-06	0.00347	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	4.11e-06	0.00346	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.94e-06	0.00331	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SRM—multiple sclerosis	3.93e-06	0.00331	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	3.82e-06	0.00322	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.67e-06	0.00309	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—POMC—multiple sclerosis	3.64e-06	0.00306	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.6e-06	0.00303	CbGpPWpGaD
Tenoxicam—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.53e-06	0.00297	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.37e-06	0.00284	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	3.35e-06	0.00282	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.27e-06	0.00275	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.27e-06	0.00275	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	3.25e-06	0.00274	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SRM—multiple sclerosis	3.12e-06	0.00262	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	2.97e-06	0.00249	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	2.9e-06	0.00244	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	2.89e-06	0.00243	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP27B1—multiple sclerosis	2.77e-06	0.00233	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP24A1—multiple sclerosis	2.77e-06	0.00233	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	2.73e-06	0.0023	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.71e-06	0.00228	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	2.71e-06	0.00228	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	2.66e-06	0.00224	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GPC5—multiple sclerosis	2.53e-06	0.00213	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GPC5—multiple sclerosis	2.4e-06	0.00202	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	2.26e-06	0.0019	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	2.25e-06	0.0019	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	2.21e-06	0.00186	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP27B1—multiple sclerosis	2.2e-06	0.00185	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP24A1—multiple sclerosis	2.2e-06	0.00185	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.15e-06	0.00181	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	2.15e-06	0.00181	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	2.1e-06	0.00177	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—RRM1—multiple sclerosis	2.1e-06	0.00177	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SRM—multiple sclerosis	2.07e-06	0.00174	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GPC5—multiple sclerosis	2.01e-06	0.00169	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.91e-06	0.00161	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.8e-06	0.00151	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	1.7e-06	0.00143	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—RRM1—multiple sclerosis	1.67e-06	0.0014	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.63e-06	0.00137	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RPL5—multiple sclerosis	1.56e-06	0.00131	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.54e-06	0.00129	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.53e-06	0.00129	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.5e-06	0.00126	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SLC11A1—multiple sclerosis	1.5e-06	0.00126	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.46e-06	0.00122	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.46e-06	0.00122	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.43e-06	0.0012	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.42e-06	0.0012	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.4e-06	0.00118	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.33e-06	0.00112	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.29e-06	0.00109	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.28e-06	0.00107	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—BCHE—multiple sclerosis	1.21e-06	0.00101	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD28—multiple sclerosis	1.19e-06	0.001	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.11e-06	0.000934	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.1e-06	0.000928	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.01e-06	0.000852	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—BCHE—multiple sclerosis	9.57e-07	0.000805	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.56e-07	0.00072	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD86—multiple sclerosis	8.52e-07	0.000717	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CCR5—multiple sclerosis	7.56e-07	0.000636	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HLA-A—multiple sclerosis	7.36e-07	0.000619	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.35e-07	0.000619	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—APOE—multiple sclerosis	7.25e-07	0.00061	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—APOE—multiple sclerosis	6.87e-07	0.000578	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.7e-07	0.000564	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.34e-07	0.000533	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—POMC—multiple sclerosis	6.23e-07	0.000524	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD80—multiple sclerosis	6.21e-07	0.000523	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—APOE—multiple sclerosis	5.76e-07	0.000484	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALB—multiple sclerosis	5.68e-07	0.000478	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TYK2—multiple sclerosis	5.25e-07	0.000441	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—POMC—multiple sclerosis	4.95e-07	0.000416	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CD4—multiple sclerosis	4.74e-07	0.000399	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALB—multiple sclerosis	4.51e-07	0.000379	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—APOE—multiple sclerosis	3.81e-07	0.000321	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—STAT3—multiple sclerosis	3.67e-07	0.000309	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MYC—multiple sclerosis	3.41e-07	0.000287	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TGFB1—multiple sclerosis	3.41e-07	0.000286	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MAPK1—multiple sclerosis	3.34e-07	0.000281	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—POMC—multiple sclerosis	3.27e-07	0.000275	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALB—multiple sclerosis	2.99e-07	0.000251	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—IL6—multiple sclerosis	2.57e-07	0.000216	CbGpPWpGaD
